• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房医院获得性血流感染的结局及其相关因素

The Outcome of Hospital-Acquired Bloodstream Infection and Its Associated Factors in Critical Care Unit.

作者信息

Mohamed Shukri Nurul Rahatul Ilyani, Hassan Shamsul Kamalrujan, Md Noor Siti Suraiya, Ab Hamid Siti Azrin, Nik Mohamad Nik Abdullah, Wan Muhd Shukeri Wan Fadzlina, Mazlan Mohd Zulfakar

机构信息

Department of Anaesthesiology and Intensive Care, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.

Hospital Pakar Universiti Sains Malaysia, Kelantan, Malaysia.

出版信息

Malays J Med Sci. 2024 Dec;31(6):160-177. doi: 10.21315/mjms2024.31.6.13. Epub 2024 Dec 31.

DOI:10.21315/mjms2024.31.6.13
PMID:39830098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11740822/
Abstract

BACKGROUND

Hospital-acquired bloodstream infections (BSI) are associated with high morbidity and mortality rates. This study was conducted to describe the outcomes and the prognosis of hospital-acquired BSI in the Critical Care Unit, Hospital Pakar Universiti Sains Malaysia (HPUSM), as well as to identify associated factors of treatment failure and mortality at 28 days.

METHODS

This prospective cohort study was conducted in the Critical Care Unit of HPUSM from September 2019 to March 2021. Eligible participants included patients with a positive blood culture recorded after 48 hours of admission to hospital.

RESULTS

There was a total of 250 patients, whose positive blood cultures were isolated. The main isolated organisms were (23.6%), spp. (19.2%), (12.8%) and (9.2%). The mortality of hospital-acquired BSI was 27.6%. Multiple logistic regression analysis revealed that age [adjusted odds ratio (OR) = 1.06; 95% confidence interval (CI): 1.03, 1.09; < 0.001], cases with extended-spectrum beta-lactamases (ESBL) (adjusted OR = 5.57; 95% CI: 2.04, 15.21; = 0.001), with multidrug-resistant (MDR) organisms (adjusted OR = 14.70; 95% CI: 3.97, 54.48; < 0.001) and those with a sequential organ failure assessment (SOFA) score > 11 (adjusted OR = 4.16; 95% CI: 1.31, 13.19; = 0.015) had statistically significant associations with treatment failure. Factors significantly associated with 28-day mortality included age (adjusted OR: 1.06: 95% CI; 1.03, 1.09; < 0.001), MDR organisms (adjusted OR = 14.70; 95% CI: 3.97, 54.48; < 0.001) and SOFA score > 11 (adjusted OR = 4.16; 95% CI: 1.31, 13.19; = 0.015).

CONCLUSION

The elderly, ESBL, MDR organisms and high SOFA scores were associated with treatment failure and 28-day mortality in hospital-acquired BSI.

摘要

背景

医院获得性血流感染(BSI)与高发病率和死亡率相关。本研究旨在描述马来西亚理科大学专科医院(HPUSM)重症监护病房医院获得性BSI的结局和预后,并确定28天治疗失败和死亡的相关因素。

方法

这项前瞻性队列研究于2019年9月至2021年3月在HPUSM重症监护病房进行。符合条件的参与者包括入院48小时后血培养记录为阳性的患者。

结果

共分离出250例血培养阳性患者。主要分离出的病原体为(23.6%)、 属(19.2%)、(12.8%)和(9.2%)。医院获得性BSI的死亡率为27.6%。多因素logistic回归分析显示,年龄[调整优势比(OR)=1.06;95%置信区间(CI):1.03,1.09;<0.001]、产超广谱β-内酰胺酶(ESBL)病例(调整OR=5.57;95%CI:2.04,15.21;=0.001)、多重耐药(MDR)病原体(调整OR=14.70;95%CI:3.97,54.48;<0.001)以及序贯器官衰竭评估(SOFA)评分>11的患者(调整OR=4.16;95%CI:1.31,13.19;=0.015)与治疗失败有统计学显著关联。与28天死亡率显著相关的因素包括年龄(调整OR:1.06:95%CI;1.03,1.09;<0.001)、MDR病原体(调整OR=14.70;95%CI:3.97,54.48;<0.001)和SOFA评分>11(调整OR=4.16;95%CI:1.31,13.19;=0.015)。

结论

老年人、ESBL、MDR病原体和高SOFA评分与医院获得性BSI的治疗失败和28天死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0443/11740822/69683adba1f0/13mjms3106_oaf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0443/11740822/69683adba1f0/13mjms3106_oaf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0443/11740822/69683adba1f0/13mjms3106_oaf1.jpg

相似文献

1
The Outcome of Hospital-Acquired Bloodstream Infection and Its Associated Factors in Critical Care Unit.重症监护病房医院获得性血流感染的结局及其相关因素
Malays J Med Sci. 2024 Dec;31(6):160-177. doi: 10.21315/mjms2024.31.6.13. Epub 2024 Dec 31.
2
Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis.实体癌合并血流感染患者中多重耐药菌的流行情况及影响:25 年趋势分析。
Microbiol Spectr. 2024 Oct 3;12(10):e0296123. doi: 10.1128/spectrum.02961-23. Epub 2024 Aug 28.
3
Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.重症监护病房中产超广谱β-内酰胺酶大肠埃希菌和克雷伯菌属血流感染危险因素的评估;抗生素管理及临床结局
J Hosp Infect. 2008 Feb;68(2):108-15. doi: 10.1016/j.jhin.2007.10.011. Epub 2007 Dec 11.
4
Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study.重症监护病房中终末期肾病患者碳青霉烯类耐药革兰阴性菌血流感染的临床结局:一项多中心回顾性观察研究
Infection. 2025 Feb;53(1):197-207. doi: 10.1007/s15010-024-02343-5. Epub 2024 Jul 12.
5
Microbiological and Clinical Characteristics of Bloodstream Infections in General Intensive Care Unit: A Retrospective Study.综合重症监护病房血流感染的微生物学及临床特征:一项回顾性研究
Front Med (Lausanne). 2022 Apr 28;9:876207. doi: 10.3389/fmed.2022.876207. eCollection 2022.
6
Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection.重症监护病房获得性血流感染的流行病学和预后。
Am J Trop Med Hyg. 2020 Jul;103(1):508-514. doi: 10.4269/ajtmh.19-0877. Epub 2020 Apr 16.
7
Bloodstream Infections in a Nepalese Tertiary Hospital-Aetiology, Drug Resistance and Clinical Outcome.尼泊尔一家三级医院的血流感染——病因、耐药性及临床结果
J Nepal Health Res Counc. 2024 Dec 20;22(3):574-581. doi: 10.33314/jnhrc.v22i03.5217.
8
[Current analysis of bloodstream infections in adult intensive care unit patients: a multi-center cohort study of China].[成人重症监护病房患者血流感染的现状分析:一项中国多中心队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Mar;37(3):232-236. doi: 10.3760/cma.j.cn121430-20240923-00791.
9
Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.成人恶性肿瘤患者血流感染:流行病学、微生物学以及与死亡率和多重耐药相关的危险因素。
BMC Infect Dis. 2021 Jul 2;21(1):636. doi: 10.1186/s12879-021-06243-z.
10
The impact of ageing on the incidence and mortality rate of bloodstream infection: A hospital-based case-cohort study in a tertiary public hospital of Brazil.老龄化对血流感染发病率和死亡率的影响:巴西一家三级公立医院基于医院的病例队列研究
Trop Med Int Health. 2021 Oct;26(10):1276-1284. doi: 10.1111/tmi.13650. Epub 2021 Jul 21.

本文引用的文献

1
Predictors of Treatment Failure and Mortality among Patients with Septic Shock Treated with Meropenem in the Intensive Care Unit.重症监护病房中接受美罗培南治疗的感染性休克患者治疗失败和死亡的预测因素
Malays J Med Sci. 2024 Feb;31(1):76-90. doi: 10.21315/mjms2024.31.1.7. Epub 2024 Feb 28.
2
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.重症监护病房获得性血流感染患者的流行病学和结局:EUROBACT-2 国际队列研究。
Intensive Care Med. 2023 Feb;49(2):178-190. doi: 10.1007/s00134-022-06944-2. Epub 2023 Feb 10.
3
Personalized infection prevention and control: identifying patients at risk of healthcare-associated infection.
个性化感染预防与控制:识别发生医院感染的高风险患者。
J Hosp Infect. 2021 Aug;114:32-42. doi: 10.1016/j.jhin.2021.03.032.
4
Burden of bloodstream infection in older persons: a population-based study.老年人血流感染负担:一项基于人群的研究。
BMC Geriatr. 2021 Jan 7;21(1):31. doi: 10.1186/s12877-020-01984-z.
5
The Prevalence, Risk Factors, and Outcomes of Sepsis in Critically Ill Patients in China: A Multicenter Prospective Cohort Study.中国重症患者脓毒症的患病率、危险因素及预后:一项多中心前瞻性队列研究
Front Med (Lausanne). 2020 Dec 17;7:593808. doi: 10.3389/fmed.2020.593808. eCollection 2020.
6
Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection.重症监护病房获得性血流感染的流行病学和预后。
Am J Trop Med Hyg. 2020 Jul;103(1):508-514. doi: 10.4269/ajtmh.19-0877. Epub 2020 Apr 16.
7
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
8
Chronic kidney disease and the gut microbiome.慢性肾脏病与肠道微生物群
Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1211-F1217. doi: 10.1152/ajprenal.00298.2018. Epub 2019 Mar 13.
9
Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study.马拉维一家大型城市医院血流感染分离株的抗菌药物耐药性趋势(1998 - 2016年):一项监测研究
Lancet Infect Dis. 2017 Oct;17(10):1042-1052. doi: 10.1016/S1473-3099(17)30394-8. Epub 2017 Aug 14.
10
Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome.越南北方一家三级传染病医院的细菌血流感染:病因、耐药性及治疗结果
BMC Infect Dis. 2017 Jul 12;17(1):493. doi: 10.1186/s12879-017-2582-7.